ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Medical Properties Trust stock price: buy the dip or sell the MPW rip?

By: Invezz
tenet healthcare sell hospitals novant health

Medical Properties Trust (NYSE: MPW) stock price has sunk to its lowest level since August 2012, making it one of the worst-performing REITs in the US. The shares were trading at $4.60 on Monday, down by over 77% from its highest level on record. Its market cap has plunged to over $2.7 billion.

Short interest rises

Medical Properties Trust is a Real Estate Investment Trust (REIT) that acquires and manages assets in the healthcare sector. Most of its properties are in the general acute care hospitals followed by behavioral health facilities and inpatient rehabiltation facilities. Its assets are valued at over $19 billion.

MPW has been in trouble in the past few months, which explains why its stock has plunged while its short interest is nearing 30%. Short interest is a figure that shows the percentage of shares that are held short by investors. This means that these short-sellers have benefited as the stock plunged.

Medical Properties Trust’s woes have seen it slash its dividend and report weak financial results. It reported weak financial results a few weeks ago. The results revealed that its net income dropped to $117 million in Q3, down from $222 million in the same quarter in 2022. 

Its Net Funds From Operations (NFFO) came in at $226 million, down from $272 million in Q3’22. As a result, the company lowered its forward guidance of its net income. It expects that its net income will be between $0.36 to $0.38.

The challenge for Medical Properties Trust is that its balance sheet is quite leveraged, with over $10.1 billion in debt. This is a sizable amount considering that its total assets stand at about $19.1 billion. 

Worse, some of its debt is based on a floating rate, which equals to about 15% of the total debt capital. Floating debt is risky in a period when interest rates are expected to remain at a 22-year high for months.

Despite these challenges, the management has made some important but tough decisions. It has slashed its dividend payouts in a bid to preserve cash. It is also focused on paying back the credit revolver facility of about $1.5 billion and selling some of its assets.

Medical Properties Trust share price forecast

MPW chart by TradingView

Turning to the weekly chart, we see that the MPW share price has been in a freefall in the past few months. The stock recently retreated below the key resistance point at $6.70, the lowest swing on March 20th. 

It also slipped below the crucial support at $9.54, the lowest point in March 2020. It remains below the 50-week and 100-week Exponential Moving Averages (EMA). The Relative Strength Index (RSI) has moved slightly above the oversold level. Therefore, the outlook for the stock is bearish for now, with the next point to watch will be at $3.50. This view is in line with my last MPW forecast. Still, I suspect that the company will bounce back in 2024 as the Fed starts or provide hints about rate cuts.

The post Medical Properties Trust stock price: buy the dip or sell the MPW rip? appeared first on Invezz

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.